Yara Voss de Lima
Biographic Data
| ID | 9065121 |
|---|---|
| NAME | Yara Voss de Lima |
| GIVEN NAMES | Yara Voss |
| FAMILY NAME | de Lima |
| SIGNATURE | DE LIMA Y V |
| AFFILIATIONS | Instituto Nacional de Saúde |
| ORCID | 0000-0001-6618-3995 |
| VERIFIED | Yes |
| TOTAL WORKS | 3 |
| TOTAL CITATIONS | 0 |
| WORKS AS AUTHOR | 3 |
| WORKS AS EDITOR | 0 |
| FIRST PUBLICATION YEAR | 2023 |
| LATEST PUBLICATION YEAR | 2025 |
| H-INDEX | 0 |
Integrating Covid-19 vaccination into health systems
INTRODUCTION: In May 2023, when the WHO declared that COVID-19 was no longer a public health emergency of international concern, countries began considering transitioning from the emergency phase to routine provision of COVID-19 vaccination. This paper presents the experience of seven countries with integrating COVID-19 vaccination into other health services and health system functions. METHODS: Data collection took place between August 2023 and …
Acceptability of decentralizing childhood tuberculosis diagnosis in low-income countries with high tuberculosis incidence
Decentralizing childhood tuberculosis services, including diagnosis, is now recommended by the WHO and could contribute to increasing tuberculosis detection in high burden countries. However, implementing microbiological tests and clinical evaluation could be challenging for health care workers (HCWs) in Primary Health Centers (PHCs) and even District Hospitals (DHs). We sought to assess the acceptability of decentralizing a comprehensive childho…
Estimating the effect of a rifampicin resistant tuberculosis diagnosis by the Xpert MTB/RIF assay on two-year mortality
Studies assessing patient-centred outcomes of novel rifampicin resistant tuberculosis (RR-TB) diagnostics are rare and mostly apply conventional methods which may not adequately address biases. Even though the Xpert MTB/RIF molecular assay was endorsed a decade ago for simultaneous diagnosis of tuberculosis and RR-TB, the impact of the assay on mortality among people with RR-TB has not yet been assessed. We analysed data of an observational prosp…
No prominent works on this page.
Acceptability of decentralizing childhood tuberculosis diagnosis in low-income countries with high tuberculosis incidence
Decentralizing childhood tuberculosis services, including diagnosis, is now recommended by the WHO and could contribute to increasing tuberculosis detection in high burden countries. However, implementing microbiological tests and clinical evaluation could be challenging for health care workers (HCWs) in Primary Health Centers (PHCs) and even District Hospitals (DHs). We sought to assess the acceptability of decentralizing a comprehensive childho…
Estimating the effect of a rifampicin resistant tuberculosis diagnosis by the Xpert MTB/RIF assay on two-year mortality
Studies assessing patient-centred outcomes of novel rifampicin resistant tuberculosis (RR-TB) diagnostics are rare and mostly apply conventional methods which may not adequately address biases. Even though the Xpert MTB/RIF molecular assay was endorsed a decade ago for simultaneous diagnosis of tuberculosis and RR-TB, the impact of the assay on mortality among people with RR-TB has not yet been assessed. We analysed data of an observational prosp…
Integrating Covid-19 vaccination into health systems
INTRODUCTION: In May 2023, when the WHO declared that COVID-19 was no longer a public health emergency of international concern, countries began considering transitioning from the emergency phase to routine provision of COVID-19 vaccination. This paper presents the experience of seven countries with integrating COVID-19 vaccination into other health services and health system functions. METHODS: Data collection took place between August 2023 and …
Medicine (3 works) · Nursing (2 works) · Tuberculosis (2 works) · Tuberculosis Research and Epidemiology (2 works) · Advanced Causal Inference Techniques (1 work) · Business (1 work) · Civil society (1 work) · Confounding (1 work) · Economic growth (1 work) · Environmental health (1 work)